ARPM: a market in exchange for investment
The Association of Russian Pharmaceutical Manufacturers participates in the largest pharmaceutical exhibition in Asia, CPhI & ICSE China. One of the main goals of the trip is to support international scientific research and clinical trials in the field of pharmaceuticals.
More than 100 countries participate in the exhibition in Shanghai, including the leading Russian pharmaceutical companies. Domestic manufacturers will offer their Asian colleagues their high-quality pharmaceutical products and production capabilities, as well as natural ingredients for the creation of medicines and much more.
An integral part of the exhibition is an international summit meeting. A conference on healthcare and pharmaceutical market modernization is planned. The business program includes meetings, discussions and visits to industry-related institutions. Highlights of discussion: new pharmaceutical products and global pharmaceutical practice. Negotiations at CPhi & ICSE China will continue from 18 to 20 June. During this time many new mutually beneficial contracts are expected to be signed.
ARPM Director-General Victor Dmitriev noted that “the main task is the transition to a new level of relations: the creation of joint ventures and the implementation of joint projects. The Chinese pharmaceutical market is currently developing at a rapid pace. According to analysts, the volume of the pharmaceutical market of China increases annually by 12%. China will be the world's fifth largest medical product market. ”
Recall that the Association of Russian Pharmaceutical Manufacturers and the All-China Association of Export-Import of Pharmaceutical and Health Products for many years successfully cooperate in the circulation of medicines and contribute to strengthening and developing interregional cooperation between Russia and China in every way.